VRTX

Vertex Pharmaceuticals
VRTX

Latest price

-

Financial Snapshot

gainify

Market Data

Market Cap
$131.61B
EV
$122.14B
Shares Outstanding
256.79M
Beta
0.41

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$496.78
P/E 2025E
28.37x
P/Revenue 2025E
10.99x

About Vertex Pharmaceuticals Incorporated

gainify
VRTX

Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/...

Sector

Healthcare

Industry

Biotechnology

CEO

Kewalramani, Reshma

Employees

6,100

IPO Date

1991-07-24

Headquarters

50 Northern Avenue, Boston, Massachusetts, 02210, United States

© Copyright 2024, All Rights Reserved